Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIMICS trial
2024-512107-39-00Phase 3Authorised
- Sponsor
- Catharina Ziekenhuis
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain and complications of surgical procedures comparing CWI with bupivacaine with CWI with placebo (saline) (2 arms). Primary endpoint: Postoperative recovery (QoR score). Planned start Jul 2024; status: authorised.
02
Drugs
bupivacaine
03
Conditions
postoperative paincomplications of surgical procedures
Beyond the preview
Go deeper on 2024-512107-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512107-39-00.